← Open Payments lookup

KIMBERLY KELLEY: Open Payments

NPI 1750032645 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,169 in 188 payments from 13 companies in 2025. Trend: 2023 $2,161 · 2024 $2,852 · 2025 $4,169

Food & beverage: $4,057Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.32$700
Neurocrine BioSciences, Inc.21$530
Otsuka America Pharmaceutical, Inc.23$485
Alkermes, Inc.18$425
E.R. Squibb & Sons, L.L.C.23$370
Vanda Pharmaceuticals Inc.17$350
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$308
Axsome Therapeutics, Inc.5$273
Janssen Pharmaceuticals, Inc12$262
Lundbeck LLC20$230

Products named: INGREZZA, UZEDY, COBENFY, FANAPT, ABILIFY MAINTENA, CAPLYTA, ARISTADA, Auvelity.

Industry payments across MS — which companies pay providers there.